4.65
price up icon9.93%   0.42
after-market 시간 외 거래: 4.61 -0.04 -0.86%
loading
전일 마감가:
$4.23
열려 있는:
$4.19
하루 거래량:
51,425
Relative Volume:
0.80
시가총액:
$3.15M
수익:
$5.49M
순이익/손실:
$-6.35M
주가수익비율:
-0.879
EPS:
-5.29
순현금흐름:
$-6.51M
1주 성능:
-8.46%
1개월 성능:
-19.83%
6개월 성능:
-29.37%
1년 성능:
-38.83%
1일 변동 폭
Value
$4.09
$4.99
1주일 범위
Value
$3.65
$5.1341
52주 변동 폭
Value
$2.414
$15.70

Inmed Pharmaceuticals Inc Stock (INM) Company Profile

Name
명칭
Inmed Pharmaceuticals Inc
Name
전화
(604) 669-7207
Name
주소
1445-885 WEST GEORGIA ST., VANCOUVER
Name
직원
13
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
INM's Discussions on Twitter

INM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
INM 4.65 3.15M 5.49M -6.35M -6.51M -5.29
VRTX 450.37 115.10B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.07B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.20B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 25.09B 3.30B -501.07M 1.03B 11.54

Inmed Pharmaceuticals Inc 주식(INM)의 최신 뉴스

pulisher
04:18 AM

InMed Pharmaceuticals (FRA:MWG) EBITDA : €-6.11 Mil (TTM As of Sep. 2024) - GuruFocus.com

04:18 AM
pulisher
02:39 AM

InMed Pharmaceuticals (STU:MWG) Earnings per Share (Diluted) : €-59.16 (TTM As of Sep. 2024) - GuruFocus.com

02:39 AM
pulisher
02:27 AM

InMed Pharmaceuticals (STU:MWG) Asset Turnover : 0.11 (As of Sep. 2024) - GuruFocus.com

02:27 AM
pulisher
02:27 AM

InMed Pharmaceuticals (STU:MWG) Intrinsic Value: DCF (Earni - GuruFocus.com

02:27 AM
pulisher
02:21 AM

InMed Pharmaceuticals (STU:MWG) Free Cash Flow : €-6.08 Mil (TTM As of Sep. 2024) - GuruFocus.com

02:21 AM
pulisher
02:11 AM

InMed Pharmaceuticals (STU:MWG) COGS-to-Revenue : 0.61 (As of Sep. 2024) - GuruFocus.com

02:11 AM
pulisher
02:10 AM

InMed Pharmaceuticals (STU:MWG) Earnings Yield (Joel Greenb - GuruFocus.com

02:10 AM
pulisher
11:57 AM

InMed Pharmaceuticals (STU:MWG) Price-to-Owner-Earnings : (As of Nov. 21, 2024) - GuruFocus.com

11:57 AM
pulisher
11:57 AM

InMed Pharmaceuticals (STU:MWG) Cash-to-Debt : 5.28 (As of Sep. 2024) - GuruFocus.com

11:57 AM
pulisher
11:57 AM

InMed Pharmaceuticals (STU:MWG) Cyclically Adjusted PB Rati - GuruFocus.com

11:57 AM
pulisher
08:33 AM

InMed Pharmaceuticals (STU:MWG) Cyclically Adjusted FCF per Share : €-485.97 (As of Sep. 2024) - GuruFocus.com

08:33 AM
pulisher
12:54 PM

InMed Pharmaceuticals (STU:MWG) Cyclically Adjusted Book pe - GuruFocus.com

12:54 PM
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Forward Dividend Yield % : 0.00% (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Cyclically Adjusted PS Rati - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Inventories, Finished Goods : €0.84 Mil (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) 3-Year Book Growth Rate : -64.40% (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Other Current Liabilities : €0.21 Mil (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) EPS (Basic) : €-59.16 (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Other Long-Term Liabilities : €0.00 Mil (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Cash From Discontinued Inve - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Other Long Term Assets : €0.09 Mil (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Cash Ratio : 3.89 (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Cash Flow from Investing : €-0.01 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) EBIT : €-6.66 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (FRA:MWG) Peter Lynch Fair Value : €-1,493.15 (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Cash From Other Investing A - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Dividend Payout Ratio : 0.00 (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Long-Term Capital Lease Obl - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Total Stockholders Equity : €7.56 Mil (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) EV-to-EBITDA : 0.22 (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Cyclically Adjusted Revenue per Share : €68.91 (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Purchase Of Investment : €-0.04 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Change In Receivables : €-0.11 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) 3-Year EPS without NRI Grow - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) EPS without NRI : €-59.73 (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Other Stockholders Equity : €-0.00 Mil (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Change In Inventory : €-0.28 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Net Issuance of Preferred S - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) EPS (Diluted) : €-59.16 (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

InMed Pharmaceuticals (STU:MWG) Short-Term Capital Lease Ob - GuruFocus.com

Nov 20, 2024
pulisher
Nov 19, 2024

InMed’s Study Highlights Cannabinol’s Potential in Skincare - TipRanks

Nov 19, 2024
pulisher
Nov 19, 2024

InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System - Newsfile

Nov 19, 2024
pulisher
Nov 18, 2024

InMed Pharmaceuticals Reports Improved Quarterly Earnings - TipRanks

Nov 18, 2024
pulisher
Nov 17, 2024

InMed Pharmaceuticals (STU:MWG) Debt-to-EBITDA : -0.13 (As of Jun. 2024) - GuruFocus.com

Nov 17, 2024
pulisher
Nov 17, 2024

InMed Pharmaceuticals (STU:MWG) 3-Year Revenue Growth Rate : 0.00% (As of Jun. 2024) - GuruFocus.com

Nov 17, 2024
pulisher
Nov 17, 2024

InMed Pharmaceuticals (STU:MWG) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com

Nov 17, 2024
pulisher
Nov 17, 2024

InMed Pharmaceuticals (STU:MWG) Growth Rank : 0 (As of Nov. 17, 2024) - GuruFocus.com

Nov 17, 2024
pulisher
Nov 16, 2024

InMed Pharmaceuticals (STU:MWG) Issuance of Stock : €4.27 Mil (TTM As of Jun. 2024) - GuruFocus.com

Nov 16, 2024
pulisher
Nov 16, 2024

InMed Pharmaceuticals (STU:MWG) Change In Working Capital : €-0.33 Mil (TTM As of Jun. 2024) - GuruFocus.com

Nov 16, 2024
pulisher
Nov 16, 2024

InMed Pharmaceuticals (STU:MWG) Net Issuance of Debt : €0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Nov 16, 2024

Inmed Pharmaceuticals Inc (INM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Inmed Pharmaceuticals Inc 주식 (INM) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
HULL ANDREW
Director
Feb 21 '24
Buy
0.39
37,500
14,625
38,258
ADAMS ERIC A
President & CEO
Feb 20 '24
Buy
0.36
41,600
14,922
43,959
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
자본화:     |  볼륨(24시간):